Clinical Trial Update: Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety trial for ApoPharma's candidate therapy in chronic diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ApoPharma experimental therapy

Snippet

Sponsor: ApoPharma | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: TERMINATED